Cited by 112Artificial Intelligence in Healthcare and EducationHealthcare RegulationDigitalization, Law, and Regulation

How the FDA regulates AI

Harvey, H. Benjamin, Gowda, Vrushab·2020·Academic Radiology

Abstract

Recent years have seen digital technologies increasingly leveraged to multiply conventional imaging modalities' diagnostic power. Artificial intelligence (AI) is most prominent among these in the radiology space, touted as the "stethoscope of the 21st century" for its potential to revolutionize diagnostic precision, provider workflow, and healthcare expenditure. Partially owing to AI's unique characteristics, and partially due to its novelty, existing regulatory paradigms are not well suited to balancing patient safety with furthering the growth of this new sector. The current review examines the historic, current, and proposed regulatory treatment of AI-empowered medical devices by the US Food and Drug Administration (FDA). An innovative framework proposed by the FDA seeks to address these issues by looking to current good manufacturing practices (cGMP) and adopting a total product lifecycle (TPLC) approach. If brought into force, this may reduce the regulatory burden incumbent on developers, while holding them to rigorous quality standards, maximizing safety, and permitting the field to mature.

Integrity signals

Registry

Crossref · 10.1016/j.acra.2019.09.017

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most AI devices, including oncology devices, are Class II, for which the FDA 510(k) pathway applies and requires substantial equivalence to already-cleared tools.

    “The vast majority of AI devices thus far, including those in oncology, fall under Class II, for which the FDA 510(k) pathway applies and requires the device to be”
  • The FDA regulates AI applications under Software as a Medical Device with processes similar to other SaMD and non-AI algorithms.

    “The FDA regulates AI applications under the umbrella of Software as a Medical Device (SaMD) with similar regulatory processes as other SaMD devices and non-AI algorithms (187).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Harvey, H. B., & Gowda, V.
Affiliations
Harvard University (US)
Corresponding author
Harvey, H. Benjamin
Venue
Academic Radiology
Publisher
Elsevier BV
Published
2020-01
Volume
27
Issue
1
Pages
58-61
ISSN
1076-6332 (ISSN-L)
OpenAlex
W2992147743
Cited by
112
References
12
Citations by year
2026: 12 · 2025: 28 · 2024: 22 · 2023: 15 · 2022: 16 · 2021: 12 · 2020: 6 · 2019: 1
FWCI
0.42
Type
journal article
Language
en
Open access
closed
Locations
  • Academic Radiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Healthcare Regulation
  • Social Sciences › Law › Digitalization, Law, and Regulation
Keywords
AI regulation, FDA, current good manufacturing practice, patient safety, medical device regulation, artificial intelligence in radiology, regulatory burden, quality standards
MeSH terms
Artificial Intelligence, Humans, Radiology, United States, United States Food and Drug Administration, Workflow, Patient Safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review